Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
Teva Pharmaceutical Industries Ltd. ADR-0.93% $19.32B ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback